Tempest Therapeutics Inc. buy BiotechBee
Start price
16.10.23
/
50%
€6.05
Target price
31.05.25
€12.00
Performance (%)
-49.85%
Price
13:11
€3.03
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Tempest Therapeutics Inc. is performing very badly with a performance of -49.85%. This prediction currently runs until 31.05.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Tempest Therapeutics Inc. | -2.539% | -2.539% |
iShares Core DAX® | 1.851% | 5.158% |
iShares Nasdaq 100 | 1.573% | 2.589% |
iShares Nikkei 225® | -0.412% | -2.857% |
iShares S&P 500 | 1.128% | 2.485% |
According to BiotechBee what are the pros and cons of Tempest Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Tempest Therapeutics Inc. diskutieren
Buy mit Kursziel 12,0